PLUS1
2.2841
-0.0059 (-0.26%)
-0.0059 (-0.26%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.0059 | -0.26% | 2.2841 | 09:53:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.30 | 2.26 | 2.33 | 2.29 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.27 | 2.29 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 669 | 214,666 | $ 2.30 | $ 493,108 | 861,882 | 0.499 - 4.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:53:45 | 2 | $ 2.28 | USD |
Outlook Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 290.50M | 127.18M | 105.54M | $ 8.15M | $ - | -0.99 | -1.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Outlook Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/22/2021 | 08:55 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 2/17/2021 | 08:05 | GlobeNewswire Inc. | Outlook Therapeutics to Participate in Cantor Fitzgerald’s.. |
| 2/16/2021 | 17:14 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 2/16/2021 | 17:04 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 2/16/2021 | 08:33 | Seeking Alpha | Outlook Therapeutics EPS misses by $0.03 |
| 2/16/2021 | 08:05 | GlobeNewswire Inc. | Outlook Therapeutics Reports Financial Results for First.. |
| 2/12/2021 | 08:04 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.51 | 2.55 | 1.88 | 2.29 | 2,417,019 | -0.2259 | -9.0% |
| 1 Month | 1.24 | 4.26 | 0.9285 | 2.27 | 13,001,530 | 1.04 | 84.2% |
| 3 Months | 1.17 | 4.26 | 0.9285 | 2.16 | 4,800,505 | 1.11 | 95.22% |
| 6 Months | 1.28 | 4.26 | 0.58 | 1.78 | 2,980,324 | 1.00 | 78.45% |
| 1 Year | 0.90 | 4.26 | 0.499 | 1.57 | 2,451,388 | 1.38 | 153.79% |
| 3 Years | 5.60 | 20.00 | 0.4011 | 1.88 | 1,915,833 | -3.32 | -59.21% |
| 5 Years | 5.60 | 20.00 | 0.4011 | 1.88 | 1,915,833 | -3.32 | -59.21% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
